皮肤黑色素瘤生存的性别差异:诊断时年龄、解剖部位和分期的作用——59个国家CONCORD-3研究
基于CONCORD-3数据,按性别估计59个国家皮肤黑色素瘤年龄标准化5年净生存率趋势,并分析年龄、解剖部位和分期对女性生存优势的作用。2010-2014年男性年龄标准化5年净生存率为43%-92%,女性为54%-95%,所有国家均为男性低于女性;女性在所有解剖部位和局限性疾病中均显示生存优势。
要点
- 2010-2014年所有国家男性年龄标准化5年净生存率43%-92%,低于女性54%-95%。
- 男性一般年龄更大且转移性黑色素瘤比例高于女性。
- 男性最常见部位为躯干(31%-58%),女性为下肢和髋部(26%-40%)。
核心结论
- 女性主要预后因素分布更有利,且在任何预后因素下均显示最高生存率。
- 公共卫生工作应侧重于提高对黑色素瘤早期体征的认识,尤其是东南欧的老年人,并提高东亚的认识,该地区生存率最差。
研究设计与样本
- 基于CONCORD-3数据,纳入59个国家皮肤黑色素瘤患者,按性别估计年龄标准化5年净生存率趋势。
- 患者按五个解剖部位分组:头颈部、躯干、四肢、生殖器官和未特指部位。
- 患者按五个年龄组分组:15-29、30-44、45-59、60-74和75-99岁。
- 患者按二元分期分组:非转移性与转移性。
- 采用非参数Pohar Perme估计量估计净生存率,按单年年龄、性别、种族/民族(尽可能)和各国日历年份校正背景死亡率;所有年龄估计值采用国际癌症生存标准权重标准化。
主要发现
- 男性一般年龄更大且转移性黑色素瘤比例高于女性。
- 男性最常见部位为躯干(范围31%-58%),女性为下肢和髋部(26%-40%)。
- 2010-2014年所有国家年龄标准化5年净生存率男性为43%-92%,女性为54%-95%,男性低于女性。
- 两性在较大年龄时生存率均较低。
- 女性在所有解剖部位和局限性疾病中均观察到生存优势。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: CONCORD-3 highlighted wide disparities in population-based 5-year net survival for cutaneous melanoma during 2000-2014. Studies showed a survival advantage in women, but the reasons are not completely understood. We aim to estimate trends in age-standardised 5-year net survival by sex and to examine the role of age, anatomic location and stage on the survival advantage for women worldwide. METHODS: Patients were grouped into five anatomic locations (head and neck, trunk, limbs, genital organs and not otherwise specified locations), into five age groups (15-29, 30-44, 45-59, 60-74 and 75-99 years) and into binary stage (non-metastatic vs. metastatic). We estimated net survival with the non-parametric Pohar Perme estimator, correcting for background mortality by single-year of age, sex, race/ethnicity where possible and calendar year in each country. All-ages estimates were standardised with the International Cancer Survival Standard weights. RESULTS: Men were generally older and with higher proportion of metastatic melanomas than women. Overall, the trunk was the most common location in men (range 31 %-58 %) and the lower limbs and hips in women (26 %-40 %). Age-standardised 5-year net survival was lower in men (43 %-92 %) than in women (54 %-95 %) in all countries during 2010-2014 and it was lower at older ages for both sexes. A survival advantage for women was observed for all anatomic sites and for localised disease. CONCLUSIONS: Women had a more favourable distribution of main prognostic factors, and showed highest survival for any prognostic factor. Public health efforts should focus on raising awareness of early signs of melanoma, especially among elderly in South-East Europe and to increase awareness in East-Asia, where survival was poorest.
引用
- Di Carlo V, Eberle A, Stiller C, et al. Sex differences in survival from melanoma of the skin: The role of age, anatomic location and stage at diagnosis: A CONCORD-3 study in 59 countries. Eur J Cancer. 2025. PMID: 39848111. doi:10.1016/j.ejca.2024.115213
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。